Answers are grounded in this paper and cite their sources.
Presents a study that assessed the evolution of biotechnology company business models in relation to investment trends in the European public and private markets and the biotechnology industry, as of December 2001. Review of various aspects of several business models; Discussion on investment trends in public markets; Outlook for biotechnology business models.
No takes yet. Share an insight, caveat, or question.
Fisken et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: